Monoacylglycerol lipase is a new therapeutic target for Alzheimer’s disease

Alzheimer’s disease (AD) is the most common cause of dementia among older people. There are no effective medications currently available to prevent and treat AD and halt disease progression. Monoacylglycerol lipase (MAGL) is the primary enzyme metabolizing the endocannabinoid 2-arachidonoylglycerol...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Chen, Rongqing, Zhang, Jian, Wu, Yan, Wang, Dongqing, Feng, Guoping, Tang, Ya-Ping, Teng, Zhaoqian, Chen, Chu
Format: Artigo
Jezik:Inglês
Izdano: 2012
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3513645/
https://ncbi.nlm.nih.gov/pubmed/23122958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.celrep.2012.09.030
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki